ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,314Medicare Part D Prescriptions Filled, Including Refills

Rank: 85 out of 223

$557K Total Retail Price of All Prescriptions

Rank: 50 out of 223

571 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
20% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Utah
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 571 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

9% of this provider’s 571 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

3% of this provider’s 5,803 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$76 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

13 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Utah
SIMVASTATIN 358 334 1 1
OMEPRAZOLE 220 191 2 3
LEVOTHYROXINE SODIUM 211 192 3 2
HYDROCODONE-ACETAMINOPHEN 198 129 S3 4 5
METFORMIN HCL 192 150 5 7
ZOLPIDEM TARTRATE 174 138 6 8
LISINOPRIL 168 149 7 4
CARVEDILOL 130 105 8 23
AMLODIPINE BESYLATE 128 124 9 6
TAMSULOSIN HCL 117 116 10 26
FUROSEMIDE 113 89 11 9
GABAPENTIN 112 67 12 10
PRAVASTATIN SODIUM 105 92 13 15
HYDROCHLOROTHIAZIDE 103 94 14 13
CITALOPRAM HBR 101 81 15 16
TRAZODONE HCL 99 73 16 22
LISINOPRIL-HYDROCHLOROTHIAZIDE 97 87 17 29
CYMBALTA 80 34 18 40
CELEBREX 77 63 19 42
LOSARTAN-HYDROCHLOROTHIAZIDE 77 76 19 31
SERTRALINE HCL 76 57 21 21
LANTUS 72 46 22 34
SYNTHROID 72 68 22 35
FENOFIBRATE 70 70 24 38
WARFARIN SODIUM 67 47 25 11
ATORVASTATIN CALCIUM 65 54 26 17
FLUTICASONE PROPIONATE 64 44 27 27
LOSARTAN POTASSIUM 63 49 28 14
FLUOXETINE HCL 63 48 28 24
POTASSIUM CHLORIDE 63 56 28 12
BUPROPION HCL SR 62 53 31 72
ALLOPURINOL 62 62 31 28
DONEPEZIL HCL 61 61 33 36
METOPROLOL SUCCINATE 60 55 34 20
TRAMADOL HCL 59 50 35 18
ALENDRONATE SODIUM 58 50 36 19
AMITRIPTYLINE HCL 57 40 R 37 61
CRESTOR 55 48 38 37
GLIMEPIRIDE 50 50 39 30
METFORMIN HCL ER 50 44 39 41
PROPRANOLOL HCL 50 27 39 93
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 30, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.